COST
Action B22 on "Drug development for parasitic diseases"
2003-2007
COST B22 Working Group 3 and Working Group 4 meeting on "Drug Evaluation and Preclinical Research/Development"
February 20-21, 2005, Basel, Switzerland
Swiss Tropical Institute, SEMINAR ROOM N.2
Parasite Chemotherapy
Socinstrasse 57
CH-4002 Basel
Tel. : +41 61 284 82 31
Fax : +41 61 271 86 54
E-mail : reto.brun@unibas.ch
Local Organiser: Prof. Dr. Reto BRUN
DRAFT AGENDA
Sunday, February 20, 7.30 PM
Welcome to participants and social dinner
Monday, February 21
09.00 - Adoption of agenda.
09.10 - Reto Brun (Switzerland) - WG3 chairman. Overview of the problems of in vitro drug evaluation
09.40 - Donatella Taramelli (Italy) Report on screening assays survey
10.00 - Vanessa Yardley (United Kingdom) Problems and advantages of in vivo models for parasitic diseases
Coffee break
11.00 - M Paola Costi (Italy) Exploitation of labs for rapid screening of novel compounds: measures for implementation of information
11.20 - Angus Bell (Ireland) Tools to overcome drug-resistance
11.40 - Louis Maes (Belgium) Toxicology studies: where to begin
12.00 - Maria Durisova (Slovakia) Mathematical models to predict drug efficacy
Lunch
14.00 - Piero Olliaro (WHO-TDR) The role of international organisations in drug development for parasitic diseases
14.20 - Arsalan Kharazmi (Denmark) - WG4 chairman. Overview of the problems of drug delivery systems for parasitic diseases
14.40 - Giuseppe Campiani (Italy) (Member of the STSM commission) Short Term Scientific Missions: expectations and reality
15.00 - Scoulica Effie (Greece) A laboratory in South Europe: a bridge between Middle East and North Europe.
15.15 - Daniela Jabes (NeEDPharma) How to select a lead compound from different candidates
15.30 - General Discussion and Conclusions
- Presentation of WG3 on COST web page
- Joint Activities with WG 3-WG4
- Addition of more external experts for the WG3/WG4
- Organization of experts meetings: when, subjects, key speakers etc.
- AOB